# Choice of PD-L1 immunohistochemistry assay influences clinical eligibility for gastric cancer immunotherapy

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/choice-of-pd-l1-immunohistochemistry-assay-influences-clinical-eligibility-for/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Joe Yeong,Huey Yew Jeffrey Lum,Chong Boon Teo,Benjamin Kye Jyn Tan,Yiong Huak Chan,Ryan Yong Kiat Tay,Joan Rou-En Choo,Anand D. Jeyasekharan,Qing Hao Miow,Lit‐Hsin Loo,Wei Peng Yong,Raghav Sundar |
| Citations | 109 |
| DOI | 10.1007/s10120-022-01301-0 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://link.springer.com/content/pdf/10.1007/s10120-022-01301-0.pdf |
| OpenAlex ID | https://openalex.org/W4282032524 |
| PMID | 35661944 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Benjamin Kye Jyn Tan](https://scholariq.org/researchers/benjamin-kye-jyn-tan/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.